These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12867576)

  • 1. T-cell involvement in osteoclast biology: implications for rheumatoid bone erosion.
    O'Gradaigh D; Compston JE
    Rheumatology (Oxford); 2004 Feb; 43(2):122-30. PubMed ID: 12867576
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune regulation of bone loss by Th17 cells.
    Adamopoulos IE; Bowman EP
    Arthritis Res Ther; 2008; 10(5):225. PubMed ID: 18983698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of cytokines and T lymphocytes upon osteoclast differentiation and function.
    Gillespie MT
    Arthritis Res Ther; 2007; 9(2):103. PubMed ID: 17381830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on review on T cells in bone biology.
    Smith MD
    Rheumatology (Oxford); 2004 Oct; 43(10):1314; author reply 1314-5. PubMed ID: 15448222
    [No Abstract]   [Full Text] [Related]  

  • 5. Osteoclasts, rheumatoid arthritis, and osteoimmunology.
    Sato K; Takayanagi H
    Curr Opin Rheumatol; 2006 Jul; 18(4):419-26. PubMed ID: 16763464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of interleukin-1 in bone resorption in rheumatoid arthritis.
    Strand V; Kavanaugh AF
    Rheumatology (Oxford); 2004 Jun; 43 Suppl 3():iii10-iii16. PubMed ID: 15150427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte-derived cytokines in inflammatory arthritis.
    Horwood N
    Autoimmunity; 2008 Apr; 41(3):230-8. PubMed ID: 18365837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory cells and bone loss in rheumatoid arthritis.
    Haynes DR
    Arthritis Res Ther; 2007; 9(3):104. PubMed ID: 17601357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis.
    Gengenbacher M; Sebald HJ; Villiger PM; Hofstetter W; Seitz M
    Ann Rheum Dis; 2008 May; 67(5):620-4. PubMed ID: 17720725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of a disintegrin and a metalloproteinase 8 (ADAM8) in osteoclastogenesis and pathological bone destruction.
    Ainola M; Li TF; Mandelin J; Hukkanen M; Choi SJ; Salo J; Konttinen YT
    Ann Rheum Dis; 2009 Mar; 68(3):427-34. PubMed ID: 18397961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody-mediated bone loss.
    Harre U; Kittan NA; Schett G
    Curr Osteoporos Rep; 2014 Mar; 12(1):17-21. PubMed ID: 24407713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK/OPG system.
    Tanaka S
    Am J Nephrol; 2007; 27(5):466-78. PubMed ID: 17652963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synovial fluid macrophages are capable of osteoclast formation and resorption.
    Adamopoulos IE; Sabokbar A; Wordsworth BP; Carr A; Ferguson DJ; Athanasou NA
    J Pathol; 2006 Jan; 208(1):35-43. PubMed ID: 16278818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-gamma-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL.
    Kotake S; Nanke Y; Mogi M; Kawamoto M; Furuya T; Yago T; Kobashigawa T; Togari A; Kamatani N
    Eur J Immunol; 2005 Nov; 35(11):3353-63. PubMed ID: 16220542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arthritis -- a nightmare for bone.
    Schett G
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):11-5. PubMed ID: 16489519
    [No Abstract]   [Full Text] [Related]  

  • 16. How antirheumatic drugs protect joints from damage in rheumatoid arthritis.
    Schett G; Stach C; Zwerina J; Voll R; Manger B
    Arthritis Rheum; 2008 Oct; 58(10):2936-48. PubMed ID: 18821703
    [No Abstract]   [Full Text] [Related]  

  • 17. [Secondary osteoporosis. Bisphosphonates as a possible strategy for the prevention of bone destruction in rheumatoid arthritis].
    Suzuki Y
    Clin Calcium; 2007 Dec; 17(12):1909-13. PubMed ID: 18057668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment.
    Schett G; Gravallese E
    Nat Rev Rheumatol; 2012 Nov; 8(11):656-64. PubMed ID: 23007741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoclasts in RA: diverse origins and functions.
    Le Goff B; Berthelot JM; Maugars Y; Heymann D
    Joint Bone Spine; 2013 Dec; 80(6):586-91. PubMed ID: 23731635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis.
    Edwards JR; Sun SG; Locklin R; Shipman CM; Adamopoulos IE; Athanasou NA; Sabokbar A
    Arthritis Rheum; 2006 May; 54(5):1451-62. PubMed ID: 16649193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.